Caplin Point Laboratories Ltd - 524742 - The Board Had Approved Interim Dividend For The Year Ended 31-03-2025 Along With The Audited Results. The Details Of The Same Is Enclosed Herewith.

Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT | BSE: 524742 | ISIN: INE475E01026 | Industry: Pharmaceuticals
| Mid-range Performer

2056.8000 30.70 (1.52%)

NSE Oct 10, 2025 15:31 PM

Volume: 76,725

Caplin Point Laboratories Ltd.

15 May 2025

2056.80

1.52%

Result

BSE India

The Board had approved interim dividend for the year ended 31-03-2025 along with the audited results. The details of the same is attached herewith.